PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3ß and PTP1B in situ

Histology and Histopathology

Volumn 26, Issue 12, 2011, Pages 1531-1543

  Petri, Meike Katinka ^a   Koch, P ^a   Stenzinger, A ^b   Kuchelmeister, K ^c   Nestler, U ^a   Paradowska, A ^a   Steger, K ^a   Brobeil, A ^a   Viard, M ^a   Wimmer, M ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

14 3 3 ; EGFR; Glioblastoma; Glioma; MAPK; PTPIP51; Raf 1

Indexed keywords

FAM82A2 PROTEIN, HUMAN; MESSENGER RNA; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN 14 3 3; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1B; PTPN1 PROTEIN, HUMAN; RAF PROTEIN; YWHAB PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER GRADING; ENZYMOLOGY; FEMALE; GENETICS; GERMANY; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

14-3-3 PROTEINS; ADULT; AGED; BRAIN NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GERMANY; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NEOPLASM GRADING; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS C-RAF; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SRC-FAMILY KINASES; UP-REGULATION; YOUNG ADULT;

EID: 80053993059     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Akasaki Y., Liu G., Matundan H.H., Ng H., Yuan X., Zeng Z., Black K.L. and Yu J.S. (2006). A peroxisome proliferator-activated receptorgamma agonist, troglitazone, facilitates caspase-8 and-9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells. J. Biol. Chem. 281, 6165-6174.
2. Arias-Romero L.E., Saha S., Villamar-Cruz O., Yip S.C., Ethier S.P., Zhang Z.Y. and Chernoff J. (2009). Activation of Src by protein tyrosine phosphatase 1B is required for ErbB2 transformation of human breast epithelial cells. Cancer Res. 69, 4582-4588.
3. Cao L., Cao W., Zhang W., Lin H., Yang X., Zhen H., Cheng J., Dong W., Huo J. and Zhang X. (2008). Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry. Neurosci. Lett. 432, 94-99.
4. Cao W., Yang X., Zhou J., Teng Z., Cao L., Zhang X. and Fei Z. (2010). Targeting 14-3-3 protein, difopein induces apoptosis of human glioma cells and suppresses tumor growth in mice. Apoptosis 15, 230-241.
5. Dubé N. and Tremblay M.L. (2004). Beyond the metabolic function of PTP1B. Cell Cycle. 3, 550-553.
6. Dubé N., Cheng A. and Tremblay M.L. (2004). The role of protein tyrosine phosphatase 1B in Ras signalling. Proc. Nat. Acad. Sci. USA 101, 1834-1839.
7. Ewing R.M., Chu P., Elisma F., Li H., Taylor P., Climie S., McBroom-Cerajewski L., Robinson M.D., O'Connor L., Li M., Taylor R., Dharsee M., Ho Y., Heilbut A., Moore L., Zhang S., Ornatsky O., Bukhman Y.V., Ethier M., Sheng Y., Vasilescu J., Abu-Farha M., Lambert J.P., Duewel H.S., Stewart I.I., Kuehl B., Hogue K., Colwill K., Gladwish K., Muskat B., Kinach R., Adams S.L., Moran M.F., Morin G.B., Topaloglou T. and Figeys D. (2007). Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 3, 89.
8. Gajadhar A. and Guha A. (2010). A proximity ligation assay using transiently transfected, epitope-tagged proteins: application for in situ detection of dimerized receptor tyrosine kinases. Biotechniques. 48, 145-152.
9. Halatsch M.E., Gehrke E.E., Vougioukas V.I., Bötefür I.C., A'Borhani F., Efferth T., Gebhart E., Domhof S., Schmidt U. and Buchfelder M. (2004). Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorageindependent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines. J. Neurosurg. 100, 523-533.
10. Hama T., Yuza Y., Saito Y., Ouchi J., Kondo S., Okabe M., Yamada H., Kato T., Moriyama H., Kurihara S. and Urashima M. (2009). Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma. Oncologist 14, 900-908.
11. Jin J., Smith F.D., Stark C., Wells C.D., Fawcett J.P., Kulkarni S., Metalnikov P., O'Donnell P., Taylor P., Taylor L., Zougman A., Woodgett J.R., Langeberg L.K., Scott J.D. and Pawson T. (2004). Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization. Curr. Biol. 14, 1436-1450.
12. Jutten B., Dubois L., Li Y., Aerts H., Wouters B.G., Lambin P., Theys J. and Lammering G. (2009). Binding of cetuximab to the EGFRvIII deletion mutant and its biological consequences in malignant glioma cells. Radiother. Oncol. 92, 393-398.
13. Karpel-Massler G., Schmidt U., Unterberg A. and Halatsch M.E. (2009). Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand? Mol. Cancer. Res. 7, 1000-1012.
14. Khan M.K., Hunter G.K., Vogelbaum M., Suh J.H. and Chao S.T. (2009). Evidence-based adjuvant therapy for gliomas: current concepts and newer developments. Indian J. Cancer 46, 96-107.
15. Koch P., Stenzinger A., Viard M., Märker D., Mayser P., Nilles M., Schreiner D., Steger K. and Wimmer M. (2008). The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma. J. Cell. Mol. Med. 12, 2083-2095.
16. Koch P., Viard M., Stenzinger A., Brobeil A., Tag C., Steger K. and Wimmer M. (2009a). Expression profile of PTPIP51 in mouse brain. J. Comp. Neurol. 517, 892-905.
17. Koch P., Petri M., Paradowska A., Stenzinger A., Sturm K., Steger K. and Wimmer M. (2009b). PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma. Prostate 69, 1751-1762.
18. Lopez-Gines C., Gil-Benso R., Benito R., Mata M., Pereda J., Sastre J., Roldan P., Gonzalez-Darder J. and Cerdá-Nicolás M. (2008). The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification. Neuropathology 28, 507-515.
19. Lv B.E., Yu C.E., Chen Y.Y., Lu Y., Guo J.H., Song Q.S., Ma D.L., Shi T.P. and Wang L. (2006). Protein tyrosine phophatase interacting interacting protein 51 (PTPIP51) is a novel mitochondria protein with an N-terminal mitochondrial targeting sequence and induces apoptosis. Apoptosis 11, 1489-1501.
20. McLendon R.E., Turner K., Perkinson K. and Rich J. (2007). Second messenger systems in human gliomas. Arch. Pathol. Lab. Med. 131, 1585-1590.
21. Reichardt W., Jung V., Brunner C., Klein A., Wemmert S., Romeike B.F., Zang K.D. and Urbschat S. (2003). The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas. Oncol. Rep. 10, 1275-1279.
22. Stenzinger A., Kajosch T., Tag C., Porsche A., Welte I., Hofer H.W., Steger K. and Wimmer M. (2005). The novel protein PTPIP51 exhibits tissue-and cell-specific expression. Histochem. Cell. Biol. 123, 19-28.
23. Stenzinger A., Schreiner D., Koch P., Hofer H.W. and Wimmer M. (2009). Cell-and molecular biology of the novel protein tyrosine phosphatase interacting protein 51. Int. Rev. Cell. Mol. Biol. 275, 183-246.
24. Tice D.A., Biscardi J.S., Nickles A.L. and Parsons S.J. (1999). Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. Proc. Nat. Acad. Sci. USA 96, 1415-1420.
25. Tonks N.K. and Muthuswamy S.K. (2007). A brake becomes an accelerator: PTP1B-a new therapeutic target for breast cancer. Cancer Cell 11, 214-216.
26. Yang X., Cao W., Lin H., Zhang W., Lin W., Cao L., Zhen H., Huo J. and Zhang X. (2009). Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J. Neurol. Sci. 276, 54-59.
27. Yoshimoto K., Dang J., Zhu S., Nathanson D., Huang T., Dumont R., Seligson D.B., Yong W.H., Xiong Z., Rao N., Winther H., Chakravarti A., Bigner D.D., Mellinghoff I.K., Horvath S., Cavenee W.K., Cloughesy T.F. and Mischel P.S. (2008). Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples. Clin. Cancer Res. 14, 488-493.
28. Yu C., Han W., Shi T., Lv B., He Q., Zhang Y., Li T., Zhang Y., Song Q., Wang L. and Ma D. (2008). PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway. Cell. Signal. 20, 2208-2220.
29. Zhao Y., Xiao A., Dipierro C.G., Abdel-Fattah R., Amos S., Redpath G.T., Carpenter J.E., Pieper R.O. and Hussaini, I.M. (2008). H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signalling pathway. Glia 56, 917-924.